Authors: Daniel, DG Potkin, SG Reeves, KR Swift, RH Harrigan, EP

Citation: Dg. Daniel et al., Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trial, PSYCHOPHAR, 155(2), 2001, pp. 128-134

Authors: Daniel, DG Copeland, LF

Citation: Dg. Daniel et Lf. Copeland, Ziprasidone: comprehensive overview and clinical use of a novel antipsychotic, EXPERT OP I, 9(4), 2000, pp. 819-828

Authors: Daniel, DG

Citation: Dg. Daniel, Antipsychotic treatment of psychosis and agitation in the elderly, J CLIN PSY, 61, 2000, pp. 49-52

Authors: Daniel, DG Zimbroff, DL Potkin, SG Reeves, KR Harrigan, EP Lakshminarayanan, M

Citation: Dg. Daniel et al., Ziprasidone 80 mg/day and 160 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: A 6-week placebo-controlled trial, NEUROPSYCH, 20(5), 1999, pp. 491-505

Authors: Tohen, M Sanger, TM McElroy, SL Tollefson, GD Chengappa, R Daniel, DG Petty, F Centorrino, F Wang, R Grundy, SL Greaney, MG Jacobs, TG David, SR Toma, V

Citation: M. Tohen et al., Olanzapine versus placebo in the treatment of acute mania, AM J PSYCHI, 156(5), 1999, pp. 702-709

Authors: Daniel, DG Wozniak, P Mack, RJ McCarthy, BG

Citation: Dg. Daniel et al., Long-term efficacy and safety comparison of sertindole and haloperidol in the treatment of schizophrenia, PSYCHOPH B, 34(1), 1998, pp. 61-69